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Purpose: The aim of this study is to investigate the synergistic effect of chondroitinase ABC and growth factors in the
integration of murine retinal progenitor cells (mRPCs) transplanted into Rho−/− mice.
Methods: mRPCs from P1 green fluorescent protein-transgenic mice were isolated and expanded for transplantation. All
mRPCs of 20 passages or less were transplanted into the subretinal space of B6 mice together with chondroitinase ABC,
and into Rho−/− mice combined with chondroitinase ABC, N-[N-(3, 5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-
butyl ester (DAPT), and insulin growth factor (IGF)-1. Cell counts were used to examine the migration and survival rate
of mRPCs in B6 mice. Immunohistochemistry was used to evaluate the differentiation and integration of mRPCs in B6
and Rho−/− mice.
Results: Our results show that substantial numbers of mRPCs migrated and survived in the retina when transplanted with
chondroitinase ABC into B6 and Rho−/− mice. Chondroitinase ABC disrupted the glial scar around the mRPCs in the
subretinal space. Only a few mRPCs expressed recoverin in B6 mice. More mRPCs expressed rhodopsin, recoverin, and
synaptophysin after transplantation into Rho−/− mice when combined with chondroitinase ABC and growth factors.
Conclusions: The synergistic effect of chondroitinase ABC and growth factors facilitates the anatomic integration of
mRPCs transplanted into Rho−/− mice.
Cell-replacement therapy is a novel strategy used to treat
irreversible retinal neurodegeneration diseases, such as age-
related macular degeneration (AMD) and retinitis pigmentosa
(RP), which are characterized by photoreceptor cell death
[1]. A range of studies suggests that the use of stem cells to
achieve this goal is feasible. So far, multiple cell types have
been used for research including neural progenitor cells [2],
hippocampal progenitor cells [3], bone marrow-derived cells
[4],  retinal  progenitors  cells  (RPCs)  [5],  postmitotic
photoreceptor precursor cells [6], retinally-directed human ES
cells [7], and photoreceptors derived from human induced
pluripotent stem cells [8]. All of these cells have been shown
to survive in the recipient for a few weeks and many can even
restore some visual function. Among these studies, several
types  of  recipients  have  been  used  for  transplantation,
including Rho−/− mice [5,9], laser-injury mice [10,11], rd mice,
a model of retinitis pigmentosa [12], and Crx-deficient mice
[7].
Though recent studies show some functional restoration
after subretinal cell transplantation [5-7], the low efficiency
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of  integration  remains  a  problem  for  cell-based
transplantation. Only 0.01% of transplanted cells survive and
even fewer integrate with the host retina [6]. To replace the
photoreceptor  cells,  transplanted  cells  must  migrate  and
integrate into the degenerated outer nuclear layers (ONL).
Physical  barriers  (outer  limit  membrane,  OLM),  glial
scarring, and immune rejection are three major obstacles for
the migration of donor cells [1,13-15]. In addition, activated
Müller  cells  and  microglia  are  thought  to  increase
extracellular matrix (ECM) components such as chondroitin
sulfate proteoglycans (CSPGs), which have been shown to
limit axon extension in the brain [16-20]. Also, the presence
of a glial boundary and two inhibitory molecules including
CD44  and  neurocan,  accumulated  at  the  abutting  retina’s
interface,  seemed  to  correlate  with  a  lack  of  integration.
Interestingly,  the  migration  of  cells  was  accompanied  by
increased glial reactivity within the abutting retina. Migration
may relate to matrix metalloproteinase 2 (MMP2) production
by the host glial cells, which can specifically degrade both
neurocan and CD44 [14,21]. Similarly, CSPGs play a vital
role in preventing the migration and integration of grafted
cells  into  degenerating  retina  [22].  Previously,  several
methods were employed to facilitate the movement of donor
cells, including using glial fibruillary acidic protein (GFAP)/
Vimentin knockout mice [23], progenitor cell/biodegradable
MMP2-PLGA  polymer  [24],  α-Aminoadipate  (AAA)  [25,
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Rho26], and chondroitinase ABC [22,27,28]. Chondroitinase can
promote  functional  recovery  in  the  damaged  CNS  via
disruption of extracellular matrix components [29]. It has also
been  shown  to  promote  functional  axonal  regeneration,
functional  repair,  and  plasticity  of  the  chronically  injured
spinal  cord  [30,31].  Chondroitinase  ABC  enhances
synaptogenesis between transplanted and host neurons in the
chemical-induced  model  of  retinal  degeneration  [28].
However, there is no evidence that chondroitinase can induce
differentiation.  Several  growth  factors  are  supposed  to
promote photoreceptor cell differentiation including N-[N-(3,
5-Difluorophenacetyl)  -L-alanyl]  -S-phenylglycine  t-butyl
ester  (DAPT)  and  insulin  growth  factor  (IGF)-1  [32,33].
Although great progress has been made in treating central
nervous system (CNS) diseases via the transplantation of stem
cells combining chondroitinase and growth factors, the effect
of combining chondroitinase and growth factors in eye disease
has never been investigated. In this study, we examined the
synergic effects of chondroitinase ABC, DAPT, and IGF-1 on
the differentiation and integration of mRPCs into Rho−/− mice.
METHODS
Animals: All experiments were performed in compliance with
the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research, and all experimental protocols were
approved by the Animal Care and Use Committee of the
Schepens Eye Research Institute. Green fluorescent protein
positive  (GFP+)  C57BL/6J  (B6)  mice,  C57BL/6J  mice
(Jackson Laboratory, Bar Harbor, ME) and Rhodoposin null
C57B16  mice  (Rho−/−,  Peter  Humphries,  Trinity  College,
Dublin, Ireland) were housed in a 12 h:12 h light-dark cycle
with water and food provided ad libitum.
Cell isolation and culture: Retinal progenitor cells harvested
from  the  neural  retinas  of  P1  enhanced  green  fluorescent
protein  mice  were  isolated  and  maintained  in  culture  as
previously  described  [5].  Briefly,  neural  retinas  were
dissected  from  surrounding  tissues.  Pooled  neural  retinal
tissue  was  minced  and  dissociated  enzymatically  (0.1%
collagenase  in  HBSS;  Sigma,  St.  Louis,  MO)  at  room
temperature. Liberated cells were collected through a 100 um
mesh  strainer,  centrifuged,  and  then  resuspended  in  a
neurobasal medium, which was supplemented with epidermal
growth factor (EGF; 20 ng/ml), L-glutamine (2 mM; Sigma),
nystatin (2,000 U; Sigma), penicillin/streptomycin (100 μg/
ml; Sigma), and 2% B-27 supplement and N-2 supplement
(Invitrogen, Carlsbad, CA). Subsequently, cells were fed by
50% medium exchange every 2–3 days and were passaged at
confluence. Although capable of expansion through more than
60  passages,  cells  of  20  passages  or  less  were  used  for
transplantation.
Subretinal transplantation: Mice were placed under general
anesthesia  with  an  intraperitoneal  injection  of  ketamine
(120  mg/kg)  and  xylazine  (20  mg/kg),  followed  by  local
anesthetization with 0.5% proparacaine (Accutome, Malvern,
PA) and pupil dilation with 1% tropicamide (Akorn, Lake
Forest, IL). The temperature of the mice was maintained at
37 °C during surgery using a heating pad and heat lamp.
Transplantation  was  performed  under  an  operating
microscope, as has been described [5,34]. The tip of a 30-
gauge needle (BD) was inserted through the sclera into the
intravitreal space to reduce intraocular pressure and was then
withdrawn. One μl HBSS containing RPC (approximately
100,000 cells), or combined with chondroitinase ABC (0.01
U/μl), or in a cocktail (chondroitianse ABC 0.01 U/μl, DAPT
10 μM, IGF-1 10 μg/ml) was inserted tangentially through the
sclera into the sub-retinal space. The injection, using a glass
microneedle attached to a 50 μl syringe (Hamilton, Reno, NV)
via polyethylene tubing, proceeded slowly to produce retinal
detachment in the superior hemisphere around the injection
site. There were 9 mice in each group. The age of the mice for
transplantation  was  about  6–8  weeks.  Following
transplantation, mice were allowed to recover, were returned
to their normal housing, and were left for 1 or 3 weeks post
transplantation.
Tissue preparation and histology: The B6 mice in receipt of
mRPCs transplants were euthanized at 1 week or 3 weeks after
transplantation. The Rho−/− mice were euthanized 3 weeks
after  transplantation.  The  eyes  were  fixed  in  4%
paraformaldehyde, cryoprotected in 10% and 30% sucrose in
a 0.1% phosphate buffer, and were sectioned at 8 μm on a
cryostat. Tissue sections were immunostained for chondroitin
(a marker for NG2 Chondroitin Sulfate Proteoglycan; 1:100;
Chemicon,  Temecula,  CA),  glial  fibrillary  acidic  protein
(GFAP;  a  marker  for  Müller  cells;  1:250;  Chemicon),
recoverin (1:1,000, a marker for rod and cone photoreceptors
and  some  cone  bipolar  cells;  Chemicon),  rhodopsin  (rod
photoreceptors  marker;  1:100;  Chemicon),  protein  kinase
alpha (PKCα; a marker for bipolar cells; 1:100; Santa Cruz,
Santa Cruz, CA), and synaptophysin (a marker for integral
membrane protein of small synaptic vesicles in brain and
endocrine cells; 1:100; Dako, Carpinteria, CA), followed by
reaction with Cy3-conjugated or Cy5-conjugated secondary
antibody.  Sections  were  examined  with  conventional  and
confocal microscopy.
Migration and survival evaluation: To evaluate the migration
of mRPCs, we calculated the distance that the cells migrated
into the retinal layers from the injection site. To quantify the
migrated cells’ survival, we counted the mRPCs in the retinal
layers, excluding the donor cells in the subretinal space. Cells
were counted within one random microscopy field at 40×
(n=9).
Electroretinography  recordings:  The  electroretinograms
(ERGs) of Rho−/− mice were assessed using a UTAS-E3000
recording system (LKC Technologies, Gaithersburg, MD).
Mice were dark-adapted overnight and anesthetized with a
mixture  of  ketamine/xylazine  (120  mg/kg  and  20  mg/kg,
respectively). After pupil dilatation with 1% tropicamide and
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Ganzfeld bowl (UTAS3000; LKC Technologies). The active
electrode (a gold wire loop) was placed on the cornea, the
reference electrode was placed on the head, and the ground
electrode was placed on the back. ERG responses to a series
of increasing-intensity light flashes: 0, 10, and 20 dB were
averaged over 10 separate flashes per light intensity. The a-
wave amplitude was measured from the baseline to the trough
of  the  first  negative  wave;  the  b-wave  amplitude  was
measured from the trough of the a-wave to the peak of the first
positive wave or, if the a-wave was absent, from the baseline
to the peak of the first positive wave.
Statistics:  Data  were  represented  as  mean±SD.  Statistical
analysis of the data was performed using SPSS13.0, IBM
SPSS Data Collection, Chicago, IL; significant differences
were examined with the Mann–Whitney U test. p<0.05 was
considered significant.
RESULTS
To evaluate the effect of chondroitinase ABC on the migration
of donor cells, we transplanted the mRPCs combined with
chondroitinase ABC into the subretinal space of B6 mice. The
effective concentration of chondroitinase ABC was 0.01 U/
μl,  as  shown  in  a  previous  study  [27].  Murine  retinal
progenitor cells remained in the subretinal space and seldom
migrated into the retinal layers one week after transplantation
in the control group (Figure 1C). Substantial migration of
mRPCs was seen when the transplant was combined with
chondroitinase ABC (Figure 1F). The cells had a higher ability
to  migrate  and  survive  in  the  retinal  layers  in  the
chondroitinase  ABC  treated  group  (Figure  1G,H).  The
average distance migrated from the injection site in both the
control  and  the  chondroitinase  ABC  treated  group  was
620.56±159.49  μm  and  1795.56±414.76  μm,  respectively.
The farthest distance migrated from the injection site was
2284  μm  in  the  Chondroitinase  ABC  treated  group.  The
number of cells in the retinal layers of the control group and
the chondroitinase ABC treated group was 25.56±15.63 and
99.22±23.51, respectively, (n=9).
As  shown  before,  chondroitin  sulfate  proteoglycans
(CSPG) plays an important role in preventing the migration
and  integration  of  donor  cells  [22].  One  week  after
transplantation,  chondroitin  was  upregulated  in  the  outer
nuclear layer and in the vicinity of the donor cells (Figure 2D).
Comparably, the chondroitin expression around mRPCs was
much lower in the chondroitinase ABC treated group (Figure
2H).  Also,  there  was  no  chondroitin  located  in  the  outer
nuclear layers. Three weeks after transplantation, chondroitin
was still evident in the outer nuclear layer and in the vicinity
of the cells that resided in the subretinal space (Figure 2L),
albeit with faint expression. Some donor cells extended their
dendrites in the chondroitinase ABC treated group (Figure
2P).
The mRPCs were most often seen in the subretinal space
and most expressed GFAP in the control group. Less cells
migrated  into  the  retinal  layers  (Figure  3D).  In  the
chondroitinase ABC group, the cells migrated into the retinal
layers and extended their process to the inner nuclear layer
and  inner  plexiform  layer  (Figure  3H).  Only  a  few  cells
expressed GFAP. GFAP was still seen in the inner nuclear
layer, retinal ganglion layer, and in the donor cells located in
the subretinal space (Figure 3D,H). Compared to the control
group, the cells had a higher ability to migrate and a lower
incidence of differentiation into glial cells.
We  next  transplanted  mRPC  into  the  Rho−/−  mice.
Similarly,  chondroitinase  ABC  downregulated  the
chondroitin expression around the outer nuclear area that was
induced by transplantation (Figure 4D,H). The cells located
in the subretinal space or vitreous cavity expressed GFAP,
whether in the control or chondroitinase ABC group (Figures
4L,P).  The  GFAP  expression  in  retinal  layers  in  the
chondroitinase ABC group was the same as in the control
group. However, chondroitinase ABC promoted substantial
migration of the cells into the retinal layers. GFAP expression
was not seen around the donor cells that resided in the retinal
layers (Figure 4P). Many cells migrated into the inner nuclear
layer  and  inner  plexiform  layer  with  the  employment  of
chondroitinase ABC (Figure 4Q).
To  determine  if  the  growth  factors  could  induce
differentiation in vivo, a cocktail (Chondroitinase ABC 0.01
U/μl, DAPT 10 μM, IGF1 10 ng/ml) was transplanted with
mRPCs into the Rho−/− mice. After transplantation with the
cocktail, more cells expressed rhodoposin and integrated into
the outer nuclear layer (Figure 5P,R). A cluster of cells were
recoverin-positive  and  located  in  the  outer  nuclear  layer
(Figure  5D,H,Q).  There  was  no  significant  difference  in
recoverin-positive cells between the control (Figure 5D) and
cocktail group (Figure 5H). The untreated control group is
shown in Figure 6A (Synaptophysin) and Figure 6B (PKCα).
Normally, synaptophysin is expressed in the inner plexiform
layer, whereas PKCα expression is located in the inner nuclear
layer.  The  mRPCs  extended  their  neurites  to  the  inner
plexiform layer, which is a key location for synaptic activity
(Figure  6F).  It  appeared  that  donor  cells  extended  their
neurites in the host bipolar-cell layer in morphology (Figure
6J).
DISCUSSION
Cell-replacement therapy provides a promising method for
treating irreversible retinal degenerative diseases. Choosing a
cell  source  for  transplantation  is  always  controversial.
Previously, retinal sheets were used for transplantation [13,
35,36]. Unfortunately, intact embryonic retinal sheets did not
interact or integrate with host neurons. Integration with the
host retina is much better in the transplantation of retinal
progenitor  cells.  These  cells  are  derived  from  developing
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to proliferate and generate new neurons and specialized retinal
cells. When these cells are transplanted into either the normal
or degenerate (dystrophic) retinas of rats and mice, they can
migrate  into  all  retinal  layers  and  develop  morphological
characteristics of various retinal cell types [37,38]. Though
recent  studies  show  that  Nrl+  postmitotic  photoreceptor
precursors  and  photoreceptors  derived  from  human
embryonic stem cells can integrate into the host retina and
restore some visual function, mRPCs remain a viable cell
source for the transplantation due to their easy accessibility
and multipotency. Also, we found that RPCs were able to
produce TGF-2, FasL, and IDO, indicating that RPCs could
not only suppress immunity to the transplanted allogeneic
progenitor  cells,  but  could  also  create  a  local  immune
privilege site [39]. In addition, subretinal space is an immune
privilege area. This cell- or tissue-specific immune privilege
allows  donor  material  to  survive  transplantation  to  an
allogeneic host [40].
Figure 1. Chondroitinase ABC promotes the migration of murine retinal progenior cells (mRPCs) into B6 mice. A-C: One week after
transplantation of mRPCs. D-F: One week after transplantation of mRPCs combined with Chondroitinase ABC. Murine retinal progenitor
cells gather in the subretinal space. Abundant of cells migrated into the retinal layers were seen in F. Quantification of the difference of
migration distance from the injection site (G) and the cells in the retinal layers (H). The cells in the chondroitinase ABC treated group have
a higher ability to migrate and survive in the retinal layers. Scale bar: 25 μm (C, F). G, H: The columns are mean values, error bars are SD,
*p<0.05 (n=9). Abbreviations: inner nuclear layer (INL); outer nuclear layer ONL; and subretinal space (SRS).
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repair  in  the  CNS.  Since  chondroitinase  ABC  has  been
successfully used to treat a spinal cord injury [41], several
studies have focused on using chondroitinase to promote the
functional  recovery  of  CNS  diseases  [30,42-49].
Considerably less attention has been paid to the effects of
chondroitinase ABC on eye diseases. So far, chondroitinase
ABC shows promising effects for promoting the integration
of  grafted  cells  [22,27,28].  Our  study  shows  that
chondroitinase ABC improves the migration distance of donor
cells in the retinal layers of B6 mice. The donor cells are
surrounded by chondroitin, which is the main obstacle to their
migration [22]. Removal of inhibitors promotes donor cell
movement into the retinal layers. Unfortunately, most cells
were in the inner nuclear layer and only a few cells expressed
recoverin (a marker for rod and cone photoreceptors and some
cone bipolar cells) and β-3-tubulin (data not shown). Issues
such as these may be accounted for by a variety of factors,
including overcrowding of the outer nuclear layer, the effects
of  chemotactic  factors,  and  the  lack  of  a  permissive
Figure 2. Chondroitinase ABC disrupts the chondroitin sulfate proteoglycans (CSPGs) and glial scar barrier in B6 mice. A-D: One week after
subretinal transplantation of murine retinal progenior cells (mRPCs). E-H: One week after subretinal transplantation of mRPCs combined
with Chondroitinase ABC. I-L: Three weeks after subretinal transplantation of mRPCs. M-P: Three weeks after subretinal transplantation of
mRPCs with chondroitinase ABC. Following transplantation of mRPCs and Chondroitinase ABC, the expression of chondroitin (F, N) is
much lower than that of B and J. Scale bar: 25 μm (D, H), 20 μm (L, P). Abbreviations: GCL, ganglion cell layer (GCL); inner nuclear layer
(INL); outer nuclear layer (ONL); and subretinal space (SRS).
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appropriate animal model will contribute to the migration and
differentiation of grafted cells.
Rho−/−  mice  are  B6  background  mice  developed  by
targeted disruption of the rhodopsin gene, which is an animal
model for retinitis pigmentosa. Due to the loss of rod outer
segments and photoreceptors, the Rho−/− mice may provide a
permissive environment for migration and differentiation of
donor cells. In our study, the GFAP expression was even
stronger in the outer nuclear layer and in the vicinity of the
donor cells in the subretinal space. Some recoverin-positive
cells were located in the inner nuclear layer or inner plexiform
layer.  This  finding  may  be  caused  by  three  major
transformations induced by retinal degeneration: 1) Müller
Figure 3. Glial fibrillary acidic protein (GFAP) expression of murine retinal progenior cells (mRPCs) in B6 mice. A-D: Three weeks after
transplantation of mRPCs. E-H: Three weeks after transplantation of mRPCs combined with Chondroitinase ABC. I: The average number of
GFAP-positive cells was counted per microscopic field. The columns are mean values, error bars are SD, *p<0.05 (n=9). The cells gathered
in the subretinal space almost express GFAP. Following transplantation of mRPCs and Chondroitinase ABC, the cells migrated to the retinal
layers and seldom express GFAP. Scale bar: 20 μm (D, H). Abbreviations: ganglion cell layer (GCL); inner nuclear layer (INL); outer nuclear
layer (ONL); and subretinal space (SRS).
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1764Figure 4. Three weeks post transplantation of murine retinal progenior cells (mRPCs) into Rho−/− mice. The first row (A, B, C, D) and the
third row (I, J, K, L) were mRPCs groups as control. The second row (E, F, G, H) and the fourth row (M, N, O, P) were chondroitinase ABC
treated groups. Q: The average number of cells in the retinal layers was counted per microscopic field. The columns are mean values, error
bars are SD *p<0.01 (n=9). The chondroitin expression in F was lower than that in B. Most cells migrated into the retinal layer when
Chondroitinase ABC was used (H, P). The cells express GFAP whether in the subretinal space (L) or vitreous cavity (P). None of the cells
located in the retinal layers express GFAP. Scale bar: 20 μm (D, H, L, P) Abbreviations: ganglion cell layer (GCL); inner plexiform layer
(IPL); inner nuclear layer (INL); outer nuclear layer (ONL); and subretinal space (SRS).
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1765Figure 5. Transplantation of murine retinal progenior cells (mRPCs) into Rho−/− mice combined with chondroitinase ABC or a cocktail. The
first row (A-D) and the third row (I-L): Transplantation with chondroitinase ABC. The second row (E-H) and the fourth row (M-P):
Transplantation with a cocktail. The average number of recoverin-positive (Q) or rhodopsin-positive cells (R) was counted per microscopic
field. The columns are mean values, error bars are SD *p<0.05 (n=9). The cells (arrow) are recoverin-positive in the outer nuclear layers and
inner nuclear layers (D, H). The cells express rhodopsin when they are transplanted with a cocktail (N). However, no rhodopsin-positive cells
are seen in J. Scale bar: 20 μm (D, H, L); 10 μm (P). Abbreviations: ganglion cell layer (GCL); inner nuclear layer (INL); outer nuclear layer
(ONL); and subretinal space (SRS).
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1766cell hypertrophy and elaboration of a distal glial seal between
the retina and the choroid/retinal pigmented epithelium; 2)
apparent neuronal migration along glial surfaces to ectopic
sites; and 3) rewiring through evolution of complex neurite
fascicles, new synaptic foci in the remnant inner nuclear layer,
and  new  connections  throughout  the  retina  [50].  In  the
laminar-laminar retina culture experiment, accumulation of
CRALBP, CD44, and neurocan were observed in the interface
of the abutting retina pieces. Accordingly, such integration
occurred exclusively where CRALBP, CD44, and neurocan
immunolabeling appeared to be disrupted in the interface, but
coincided with high GFAP expression within the rd1 retina.
This implies that hypertrophy and GFAP expression are not
sufficient or even appropriate indicators of a nonpermissive
environment [14]. Chondroitinase ABC can disrupt the glial
barrier and promote the migration of the donor cells. Once we
were able to make the mRPCs arrive at the correct lamina, the
differentiation  became  important  for  the  ability  to  restore
vision. We actually found that some cells resided in the outer
nuclear layer and expressed recoverin. However, none of the
donor cells differentiated into rhodopsin positive cells in a
Rho−/− host. This may be related to the complete absence of
rhodopsin expression in Rho−/− mice and a lack of incentive
factors  for  rod  differentiation.  We  hypothesize  that  the
addition of known photoreceptor inducers may increase the
levels of cellular differentiation.
In our study, the synergistic effects of chondroitinase,
DAPT,  and  IGF-1  promoted  the  differentiation  of  donor
progenitor cells into rhodopsin and recoverin positive cells.
Simultaneously,  donor  progenitor  cells  had  neuronal
sprouting. It is puzzling that only a few cells differentiated
into rod photoreceptors. There are some possible reasons for
Figure 6. Integration of murine retinal progenior cells (mRPCs) after transplantation with a cocktail (Chondroitinase ABC 0.01 U/ml, DAPT
10 uM, IGF1 10 ng/ ml) into Rho−/− mice. A: The untreated control group (Synaptophysin). B: The untreated control group (protein kinase
alpha-PKCα). The second row (C, D, E, F) and the third row (G, H, I, J) were cocktail treated group. The right panel is a merged image of
the three panels to the left. Integrated cells express the synaptophysin (arrow in D), and appear to make synaptic contact with the bipolar cells
(arrow in H). Scale bar: 20 um (A, B); 10 um (F, J). Abbreviations: ganglion cell layer (GCL); inner plexiform layer (IPL); inner nuclear
layer (INL); and outer nuclear layer (ONL); and subretinal space (SRS).
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1767this.  First,  the  Rho−/−  mice  did  not  have  the  incentive
environment for rod cell differentiation. Second, the growth
factors might have degraded quickly after two days. If we had
used the microsphere to release the growth factors slowly and
continuously, it may have greatly contributed to photoreceptor
development and induced more mRPCs to differentiate into
rod photoreceptors. We also evaluated the visual function by
ERG.  However,  we  didn’t  see  the  same  results  as  in  the
previous study [6,7]. This may relate to a low subpopulation
of photoreceptors, low rate of integration (<0.01%), or an
inappropriate period for collecting the mRPCs. Studies show
that the best ages for the donor cells are from P3 to P5, roughly
corresponding  to  two  or  three  days  following  peak  rod
photoreceptor production in a mouse retina [6]. The issue we
have  to  address  is  how  to  capture  enough  photoreceptor
precursors. However, in terms of translation into a clinical
setting, it is not feasible to collect an abundance of rod or cone
photoreceptor precursors from fetal retina for use in cell-
replacement therapy. Therefore, the differentiation between
retinal  progenitor  cells,  embryonic  stem  cells,  or  induced
pluripotent stem cells (iPSCs) is the best choice. It would be
helpful to find the key genes or growth factors related to
photoreceptor development. We have multiple options for
this:  1)  Infect  the  mRPCs  with  Crx  or  Nrl  gene  before
transplantation. With development of molecular biology, new
genes will be identified for the photoreceptor development.
This approach will definitely promote the cell-based therapy.
2)  Induce  photoreceptor  differentiation  before
transplantation. The complicated issue here is how long it will
take to induce differentiation before transplantation. If the
progenitor cells develop to mature photoreceptors they will
lose their pluripotency and it will be difficult for them to
migrate  and  integrate  into  retinal  layers.  3)  Perform
transplantation with growth factors either directly or via a
controlled release system.
In conclusion, our study shows that chondroitinase ABC
and  growth  factors  promote  the  migration  and  anatomic
integration of mRPCs into Rho−/− mice. In addition, it provides
an innovative perspective for cell-based therapy.
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